INTERNATIONAL PATENT: ACERTA PHARMA B.V. FILES APPLICATION FOR "SOLID-STATE FORMS OF ((S)-2-(3-(1-(5,5-DIMETHYLPYRROLIDINE-2-CARBONYL)PIPERIDINE-4-CARBONYL)-2-METHYL-1H-PYRROLO[2,3-C]-PYRIDIN-1-YL)-5-FLUORO-N,N-DIISOPROPYLBENZAMIDE SALTS"

GENEVA, March 30 -- ACERTA PHARMA B.V. (Kloosterstraat 95349 AB Oss) filed a patent application (PCT/EP2025/076940) for "SOLID-STATE FORMS OF ((S)-2-(3-(1-(5,5-DIMETHYLPYRROLIDINE-2-CARBONYL)PIPERIDINE-4-CARBONYL)-2-METHYL-1H-PYRROLO[2,3-C]-PYRIDIN-1-YL)-5-FLUORO-N,N-DIISOPROPYLBENZAMIDE SALTS" on Sep 19, 2025. With publication no. WO/2026/062248, the details related to the patent application was published on Mar 26, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): WU, Dedong (ASTRAZENECA PHARMACEUTICALS LP, 1800 Concord Pike, P.O. Box 15437,Wilmington, Delaware 19850-5437), ROBBINS, Andrew (...